Contract HHSN273201500014C
Experimental Pathology Laboratories, Inc. · Department Of Health And Human Services · July 10, 2024
Experimental Pathology Laboratories, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 10, 2024 for $4.07 million of work in research and development in the physical, engineering, and life sciences (except biotechnology). Performance is in Durham, NC. It was awarded under a small business set-aside. The contract has been modified 2 times since the base award It uses cost-plus contract pricing. The most recent modification was on July 24, 2025. If all options are exercised, the contract could reach $49.32 million.
Contract details
- PIID
- HHSN273201500014C
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- Small Business Set Aside - Partial
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541712 · Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology)
- Product / service
- R&D- Other Research And Development (Basic Research)
- Place of performance
- Durham, NC
- First action
- July 10, 2024
- Latest action
- July 24, 2025
Description
PATHOLOGY PEER REVIEW AND PATHOLOGY SUPPORT FOR THE DNTP AND DIR AT NIEHS. ADD, EXERCISE, AND PARTIALLY FUND OPTION PERIOD 10 TO THE CONTRACT AND EXTEND THE CONTRACT PERIOD BY 12-MONTHS. REVISE ARTICLES B.2, B.3, B.5, F.1, F.3, AND G.3.
Modification timeline
-
July 24, 2025Mod P00021 · Change Order$33.96M
-
July 22, 2024Mod P00019 · Exercise An OptionPATHOLOGY PEER REVIEW AND PATHOLOGY SUPPORT FOR THE DNTP AND DIR AT NIEHS. THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 9, YEAR 10.$31.86M
-
July 10, 2024Mod P00018 · Other Administrative ActionPATHOLOGY PEER REVIEW AND PATHOLOGY SUPPORT FOR THE DNTP AND DIR AT NIEHS$29.86M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrix Technology Llc | Department Of Health And Human Services | April 1, 2026 | $235.0K |
| Astrix Technology Llc | Department Of Health And Human Services | April 1, 2026 | $144.1K |
| Astrix Technology Llc | Department Of Health And Human Services | April 1, 2026 | $559.9K |
| Advanced Bioscience Laboratories, Inc. | Department Of Health And Human Services | March 30, 2026 | $12.94M |
| Advanced Bioscience Laboratories, Inc. | Department Of Health And Human Services | March 30, 2026 | $0 |
| Astrix Technology Llc | Department Of Health And Human Services | March 30, 2026 | $227.3K |
Top contractors in NAICS 541712
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Brookhaven Science Associates Llc | 1 | $365.69M |
| 2 | Northrop Grumman Systems Corporation | 1 | $162.00M |
| 3 | Modern Technology Solutions, Inc. | 7 | $161.71M |
| 4 | Aerojet Rocketdyne Of De, Inc | 1 | $160.86M |
| 5 | Massachusetts Institute Of Technology | 21 | $153.36M |
| 6 | Torch Technologies Inc | 7 | $90.25M |
| 7 | Tecolote Research, Inc. | 24 | $83.32M |
| 8 | Odyssey Systems Consulting Group, Ltd. | 4 | $80.71M |
| 9 | Amentum Technology, Inc. | 14 | $62.57M |
| 10 | Raytheon Company | 1 | $61.03M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN273201500014C?
Contract HHSN273201500014C is a federal contract awarded to Experimental Pathology Laboratories, Inc. by Department Of Health And Human Services on July 10, 2024 for $4.07 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract HHSN273201500014C?
Experimental Pathology Laboratories, Inc. won contract HHSN273201500014C from Department Of Health And Human Services.
How much is contract HHSN273201500014C worth?
Contract HHSN273201500014C has obligated $4.07 million to date, with a total potential value of $49.32 million if all options are exercised.